Literature DB >> 12073157

Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone.

A L Boskey1, L Spevak, E Paschalis, S B Doty, M D McKee.   

Abstract

Fourier transform infrared microspectroscopy (FTIRM) and infrared imaging (FTIRI) were used to characterize the mineral in bones of two different lines of Opn-deficient (Opn-/-) mice and their background-matched wild-type controls (Opn+/+). Sections of tibia and femur from 12-week-old and 16-week-old mice were evaluated with a spatial resolution between 10 microm (FTIRM) and 7 microm (FTIRI). FTIRI was used to examine 400 microm x 400 microm areas in cortical bone and trabecular bone and FTIRM examined selected 20 microm x 20 microm areas at sites within these anatomically defined areas. Despite the absence of an obvious phenotype in Opn-deficient mice, being undetectable by radiographic and histological methods, FTIRM analyses revealed that the relative amount of mineral in the more mature areas of the bone (central cortical bone) of Opn-knockout mice was significantly increased. Moreover, mineral maturity (mineral crystal size and perfection) throughout all anatomic regions of the Opn-deficient bone was significantly increased. The 2-dimensional, color-coded data (images) produced by FTIRI showed similar increases in mineral maturity in the Opn-/- bone, however, the crystallinity parameters were less sensitive, and significance was not achieved in all areas analyzed. Nonetheless, the findings of increased mineral content and increased crystal size/perfection in both lines of Opn-deficient mice at both ages are consistent with in vitro data indicating that Opn is a potent inhibitor of mineral formation and mineral crystal growth and proliferation, and also support a role for Opn in osteoclast recruitment and function.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2002        PMID: 12073157     DOI: 10.1007/s00223-001-1121-z

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  104 in total

Review 1.  Bone mineral crystal size.

Authors: 
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

2.  Osteopontin regulates dentin and alveolar bone development and mineralization.

Authors:  B L Foster; M Ao; C R Salmon; M B Chavez; T N Kolli; A B Tran; E Y Chu; K R Kantovitz; M Yadav; S Narisawa; J L Millán; F H Nociti; M J Somerman
Journal:  Bone       Date:  2017-12-05       Impact factor: 4.398

3.  Upregulation of osteopontin by osteocytes deprived of mechanical loading or oxygen.

Authors:  Ted S Gross; Katy A King; Natalia A Rabaia; Pranali Pathare; Sundar Srinivasan
Journal:  J Bone Miner Res       Date:  2004-10-11       Impact factor: 6.741

Review 4.  FT-IR imaging of native and tissue-engineered bone and cartilage.

Authors:  Adele Boskey; Nancy Pleshko Camacho
Journal:  Biomaterials       Date:  2006-12-18       Impact factor: 12.479

5.  Infrared spectroscopic characterization of mineralized tissues.

Authors:  Adele L Boskey; Richard Mendelsohn
Journal:  Vib Spectrosc       Date:  2005-07-29       Impact factor: 2.507

6.  Ablation of cathepsin k activity in the young mouse causes hypermineralization of long bone and growth plates.

Authors:  Adele L Boskey; Bruce D Gelb; Eric Pourmand; Valery Kudrashov; Stephen B Doty; Lyudmila Spevak; Mitchell B Schaffler
Journal:  Calcif Tissue Int       Date:  2009-01-27       Impact factor: 4.333

7.  Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum.

Authors:  Orasa Anusaksathien; Qiming Jin; Ming Zhao; Martha J Somerman; William V Giannobile
Journal:  J Periodontol       Date:  2004-03       Impact factor: 6.993

8.  A Fourier transform infrared spectroscopy analysis of carious dentin from transparent zone to normal zone.

Authors:  Y Liu; X Yao; Y W Liu; Y Wang
Journal:  Caries Res       Date:  2014       Impact factor: 4.056

9.  Adipocyte-mononuclear cell interaction, Toll-like receptor 4 activation, and high glucose synergistically up-regulate osteopontin expression via an interleukin 6-mediated mechanism.

Authors:  Devadoss J Samuvel; Kamala P Sundararaj; Yanchun Li; Maria F Lopes-Virella; Yan Huang
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

10.  Phosphoserine--a convenient compound for modification of calcium phosphate bone cement collagen composites.

Authors:  A Reinstorf; M Ruhnow; M Gelinsky; W Pompe; U Hempel; K W Wenzel; P Simon
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.